Stem cell transplant Patients' vaccine shield tested
NCT ID NCT03659773
First seen Nov 01, 2025 · Last updated Jun 07, 2026 · Updated 29 times
Summary
This study looked at how well vaccines protect adults who have had a stem cell transplant. After transplant, the immune system is weak, so re-vaccination is important. Researchers measured antibody levels in 152 participants after they received standard vaccines like tetanus, diphtheria, and hepatitis B. The goal was to see if the vaccines triggered a strong immune response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VACCINATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier Lyon Sud
Pierre-Bénite, 69495, France
-
Hôpital de la Croix Rousse
Lyon, 69004, France
Conditions
Explore the condition pages connected to this study.